This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
I'm LongbridgeAI, I can summarize articles.Top Wall Street analysts initiated coverage on several stocks with bullish outlooks. BTIG rated ICU Medical (ICUI) a Buy with a $170 target. HC Wainwright & Co. gave Biodesix (BDSX) a Buy rating and a $26 target. Needham initiated Ceva (CEVA) with a Buy and $55 target. Evercore ISI rated Lincoln International (LCLN) In-Line at $25, while JP Morgan gave ESCO Technologies (ESE) an Overweight rating with a $420 target.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Sam Eiber initiated coverage on ICU Medical Inc (NASDAQ:ICUI) with a Buy rating and announced a price target of $170. ICU Medical shares closed at $142.20 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. analyst Yi Chen initiated coverage on Biodesix Inc (NASDAQ:BDSX) with a Buy rating and announced a price target of $26. Biodesix shares closed at $15.06 on Friday. See how other analysts view this stock.
- Needham analyst Charles Shi initiated coverage on Ceva Inc (NASDAQ:CEVA) with a Buy rating and announced a price target of $55. CEVA shares closed at $46.03 on Friday. See how other analysts view this stock.
- Evercore ISI Group analyst Benjamin Rubin initiated coverage on Lincoln International Inc (NYSE:LCLN) with an In-Line rating and announced a price target of $25. Lincoln International shares closed at $24.84 on Friday. See how other analysts view this stock.
- JP Morgan analyst Tomohiko Sano initiated coverage on ESCO Technologies Inc (NYSE:ESE) with an Overweight rating and announced a price target of $420. ESCO Technologies shares closed at $313.74 on Friday. See how other analysts view this stock.
Considering buying ICUI stock? Here’s what analysts think:
Photo via Shutterstock